-
Je něco špatně v tomto záznamu ?
A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam
J. Martínková, ML. Malbrain, E. Havel, P. Šafránek, J. Bezouška, M. Kaška,
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14089
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ROAD: Directory of Open Access Scholarly Resources
od 2002
PubMed
26588478
DOI
10.5603/ait.a2015.0082
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakokinetika farmakologie MeSH
- dospělí MeSH
- inhibitory beta-laktamasy farmakokinetika farmakologie MeSH
- kritický stav * MeSH
- kyselina penicilanová analogy a deriváty farmakokinetika farmakologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- pilotní projekty MeSH
- piperacilin farmakokinetika farmakologie MeSH
- prospektivní studie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: In critically ill patients, multi-trauma and intensive therapy can influence the pharmacokinetics (PK) and pharmacodynamics (PD) of antibiotics with time-dependent bacterial killing. Consequently, PK/PD targets (%fT>MIC) - crucial for antimicrobial effects -may not be attained. METHODS: Two patients admitted to the surgical ICU of the University Hospital in Hradec Králove for multiple-trauma were given piperacillin/tazobactam by 1-hour IV infusion 4/0.5 g every 8h. PK variables: total and renal clearance (CLtot, CLR), volume of distribution (Vd), and elimination half-life (T1/2) were calculated, followed by glomerular filtration rate (MDRD) and cumulative fluid balance (CFB-total fluid volume based on 24-h registered fluid intake minus output). The PK/PD target attainment (100%fT>MIC) was defined as free (f) piperacillin plasma concentrations that remain, during the entire dosing interval (T), above the minimum inhibitory concentration (100%fT>MIC) within days 4-8 (when CFB culminates and disappears). Piperacillin concentrations were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and corrected for unbound fraction (22%). RESULTS: CFB culminated over days 2-5 reaching 15-30 L and was associated with a large Vd (29-42 L). While MDRD in patient 1 was low (0.3-0.4 mL s⁻¹ 1.7 m⁻²), that of patient 2 was increasing (> 3.1 mL s⁻¹ 1.7 m⁻²), which was associated with augmented CLR. In patient 2, the fT reached only 62, 52, and 44% on days 4, 6, and 8, respectively. In patient 1, the %fT was much higher, attaining values four to fivefold greater than that targeted. CONCLUSIONS: Critically ill patients are at risk of drug under- or overdosing without dose up-titration with regard to covariate effects and individual drug pharmacokinetics.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014217
- 003
- CZ-PrNML
- 005
- 20190114095332.0
- 007
- ta
- 008
- 170413s2016 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5603/AIT.a2015.0082 $2 doi
- 035 __
- $a (PubMed)26588478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Martínková, Jiřina
- 245 12
- $a A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam / $c J. Martínková, ML. Malbrain, E. Havel, P. Šafránek, J. Bezouška, M. Kaška,
- 520 9_
- $a BACKGROUND: In critically ill patients, multi-trauma and intensive therapy can influence the pharmacokinetics (PK) and pharmacodynamics (PD) of antibiotics with time-dependent bacterial killing. Consequently, PK/PD targets (%fT>MIC) - crucial for antimicrobial effects -may not be attained. METHODS: Two patients admitted to the surgical ICU of the University Hospital in Hradec Králove for multiple-trauma were given piperacillin/tazobactam by 1-hour IV infusion 4/0.5 g every 8h. PK variables: total and renal clearance (CLtot, CLR), volume of distribution (Vd), and elimination half-life (T1/2) were calculated, followed by glomerular filtration rate (MDRD) and cumulative fluid balance (CFB-total fluid volume based on 24-h registered fluid intake minus output). The PK/PD target attainment (100%fT>MIC) was defined as free (f) piperacillin plasma concentrations that remain, during the entire dosing interval (T), above the minimum inhibitory concentration (100%fT>MIC) within days 4-8 (when CFB culminates and disappears). Piperacillin concentrations were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and corrected for unbound fraction (22%). RESULTS: CFB culminated over days 2-5 reaching 15-30 L and was associated with a large Vd (29-42 L). While MDRD in patient 1 was low (0.3-0.4 mL s⁻¹ 1.7 m⁻²), that of patient 2 was increasing (> 3.1 mL s⁻¹ 1.7 m⁻²), which was associated with augmented CLR. In patient 2, the fT reached only 62, 52, and 44% on days 4, 6, and 8, respectively. In patient 1, the %fT was much higher, attaining values four to fivefold greater than that targeted. CONCLUSIONS: Critically ill patients are at risk of drug under- or overdosing without dose up-titration with regard to covariate effects and individual drug pharmacokinetics.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a antibakteriální látky $x farmakokinetika $x farmakologie $7 D000900
- 650 12
- $a kritický stav $7 D016638
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a kyselina penicilanová $x analogy a deriváty $x farmakokinetika $x farmakologie $7 D010397
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a piperacilin $x farmakokinetika $x farmakologie $7 D010878
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a inhibitory beta-laktamasy $x farmakokinetika $x farmakologie $7 D065093
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Malbrain, Manu L N G
- 700 1_
- $a Havel, Eduard
- 700 1_
- $a Šafránek, Petr
- 700 1_
- $a Bezouška, Jan
- 700 1_
- $a Kaška, Milan $u Surgical Department, University Hospital, Hradec Králové, Czech Republic. kaskam@lfhk.cuni.cz.
- 773 0_
- $w MED00011627 $t Anaesthesiology intensive therapy $x 1731-2515 $g Roč. 48, č. 1 (2016), s. 23-28
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26588478 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20190114095541 $b ABA008
- 999 __
- $a ok $b bmc $g 1200682 $s 974995
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 48 $c 1 $d 23-28 $e 20151120 $i 1731-2515 $m Anestezjologia, Intensywna Terapia $n Anestezjol Intens Ter $x MED00011627
- GRA __
- $a NT14089 $p MZ0
- LZP __
- $a Pubmed-20170413